Evidence map›Paper›PMID 42308255›Full record

ArticleCancer research2026

Counterfactual Diffusion Models Provide Interpretable Explanations of Artificial Intelligence Models in Pathology.

Laura Žigutytė, Tim Lenz, Tianyu Han, Nic G Reitsam, Sebastian Foersch, Katherine J Hewitt, Moritz Jesinghaus, Zunamys I Carrero, Michaela Unger, Asier Rabasco Meneghetti and 9 more

Abstract read
In one paragraph

Article in Cancer research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Dissecting and directing pathology foundation models.bioRxiv : the preprint server for biology · 2026
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

19 authors.

Laura ŽigutytėElse Kröner Fresenius Center for Digital Health (EKFZ), Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany.ORCID 0009-0000-2447-2959
Tim LenzElse Kröner Fresenius Center for Digital Health (EKFZ), Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany.ORCID 0000-0002-9034-2535
Tianyu HanDepartment of Diagnostic and Interventional Radiology, University Hospital RWTH Aachen, Aachen, Germany.ORCID 0000-0002-8636-6462
Nic G ReitsamElse Kröner Fresenius Center for Digital Health (EKFZ), Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany.ORCID 0000-0002-0070-3158
Sebastian FoerschInstitute of Pathology, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.ORCID 0000-0002-4740-6900
Katherine J HewittElse Kröner Fresenius Center for Digital Health (EKFZ), Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany.ORCID 0000-0001-6602-0141
Moritz JesinghausInstitute of Pathology, Philipps University of Marburg, Marburg, Germany.ORCID 0000-0002-0018-5661
Zunamys I CarreroElse Kröner Fresenius Center for Digital Health (EKFZ), Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany.ORCID 0000-0001-8501-1566
Michaela UngerElse Kröner Fresenius Center for Digital Health (EKFZ), Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany.ORCID 0000-0001-5811-0200
Asier Rabasco MeneghettiElse Kröner Fresenius Center for Digital Health (EKFZ), Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany.ORCID 0000-0002-1508-9410
Georg LurjeDepartment of Gastroenterology and Hepatology, Campus Charité Mitte, Campus Virchow Klinikum, Charité - Universitätsmedizin Berlin, Berlin, Germany.ORCID 0000-0001-9674-0756
Isabella LurjeDepartment of Gastroenterology and Hepatology, Campus Charité Mitte, Campus Virchow Klinikum, Charité - Universitätsmedizin Berlin, Berlin, Germany.ORCID 0000-0002-4006-7707
Sophia HerdaDepartment of Surgery, Charité - Universitätsmedizin Berlin, Berlin, Germany.ORCID 0009-0004-9359-6516
Justus PeinDepartment of Surgery, Charité - Universitätsmedizin Berlin, Berlin, Germany.ORCID 0009-0003-4902-330X
Deniz UlukDepartment of Surgery, Charité - Universitätsmedizin Berlin, Berlin, Germany.ORCID 0000-0001-6395-0845
Carolin V SchneiderDepartment of Internal Medicine III, Gastroenterology, Metabolic Diseases and Intensive Care, University Hospital RWTH Aachen, Aachen, Germany.ORCID 0000-0002-6728-9246
Alexander T PearsonSection of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, Illinois.ORCID 0000-0003-2801-7456
Daniel TruhnDepartment of Diagnostic and Interventional Radiology, University Hospital RWTH Aachen, Aachen, Germany.ORCID 0000-0002-9605-0728
Jakob Nikolas KatherElse Kröner Fresenius Center for Digital Health (EKFZ), Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany.ORCID 0000-0002-3730-5348

Funding

Integration of epidemiology, pathology, immunology and outcomes in colorectal cancerR01CA263318 · NCI · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · PI STEPHEN B GRUBER · 2022 to 2026
$3.4M
Bundesministerium für Forschung, Technologie und Raumfahrt (BMBF) 01EO2101Bundesministerium für Forschung, Technologie und Raumfahrt (BMBF) 01KD2104CBundesministerium für Forschung, Technologie und Raumfahrt (BMBF) 01KD2420ABundesministerium für Forschung, Technologie und Raumfahrt (BMBF) 01KT2302Bundesministerium für Forschung, Technologie und Raumfahrt (BMBF) 01ZU2402ABundesministerium für Forschung, Technologie und Raumfahrt (BMBF) 031L0312ABundesministerium für Forschung, Technologie und Raumfahrt (BMBF) 031L0315ABundesministerium für Forschung, Technologie und Raumfahrt (BMBF) 16DKZ2044ADeutsche Forschungsgemeinschaft (DFG) 535081457Deutsche Krebshilfe (German Cancer Aid) 70115166Deutscher Akademischer Austauschdienst (DAAD) 57616814European Research Council (ERC) 101114631Gemeinsame Bundesausschuss (G-BA) 01VSF21048HORIZON EUROPE Framework Programme (Horizon Europe) 101057091HORIZON EUROPE Framework Programme (Horizon Europe) 101096312National Institute for Health and Care Research (NIHR) NIHR203331National Institutes of Health (NIH) R01 CA263318NCI NIH HHS R01 CA263318
6 · The paper itself

Abstract

Deep learning can extract predictive and prognostic biomarkers from histopathology whole-slide images. However, explainable artificial intelligence approaches widely used in digital pathology, such as attention heatmaps and class activation mapping, provide limited insight into the image features associated with classifier outputs. In this study, we developed Morphing histoPathology Diffusion (MoPaDi), a framework for generating counterfactual explanations for histopathology images that help identify morphologic or stain-related features linked to model predictions. MoPaDi combined diffusion autoencoders with task-specific multiple instance learning classifiers to manipulate images and induce prediction shifts by modifying classifier-associated features. The framework was evaluated on multiple datasets spanning colorectal, breast, liver, and lung cancers, including tasks for tissue type, cancer subtype, and biomarker [microsatellite instability (MSI)] classification. MoPaDi generated perceptually realistic counterfactual histopathology images, enabling pathologists to identify morphologic features associated with changes in model predictions, complementing the conventional inspection of highly attended regions in digital pathology. In the MSI status prediction task, MoPaDi highlighted morphologic features linked to classifier predictions, including mucinous differentiation, altered glandular architecture, and lymphocytic infiltration, consistent with prior literature. Analyses separating stain-related from morphology-related components suggested that in this setting, prediction changes were predominantly associated with morphology-related rather than stain-related alterations. Overall, MoPaDi is a practical framework for counterfactual explanations in computational pathology that supports the evaluation of model-specific decision cues and hypothesis generation. SIGNIFICANCE: MoPaDi is a diffusion-based tool for counterfactual image generation in cancer histopathology that reveals features associated with deep learning classifier predictions and supports transparent auditing of computational models in biomedical research.

Indexed as

Artificial IntelligenceImage Processing, Computer-AssistedNeoplasmsAutoencoderDeep LearningHumans

Identifiers

PMID42308255
PMCPMC13535314

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.